B-Cell Chronic Lymphocytic Leukemia Completed Phase 1 / 2 Trials for Samalizumab (DB12636)

Also known as: B-cell Chronic Lymphocytic Leukemia / Chronic lymphocytic leukemia / Leukemia lymphocytic chronic / CLL / Chronic lymphoid leukaemia / Lymphoid leukaemia, chronic / Lymphoid leukemia, chronic / Chronic lymphatic leukaemia / Chronic lymphoid leukemia / Leukaemia lymphocytic chronic / Chronic lymphatic leukemia / Chronic lymphocytic leukaemia NOS / Leukaemias chronic lymphocytic / Chronic lymphocytic leukaemia / Leukemia, Lymphocytic, Chronic, B-Cell / Lymphoplasmacytic leukemia / B-cell chronic lymphocytic leukaemia

IndicationStatusPhase
DBCOND0030547 (B-Cell Chronic Lymphocytic Leukemia)Completed1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00648739Safety and Dose Ranging Study of ALXN6000 to Treat Relapsing or Refractory CLL or MMTreatment